Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 82Pancreatic Neoplasms 33Stomach Neoplasms 32Rectal Neoplasms 23Colonic Neoplasms 22Neoplasms 20Neoplasm Metastasis 18Esophageal Neoplasms 16Cholangiocarcinoma 14Burkitt Lymphoma 13Adenocarcinoma Of Esophagus 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Non-Small-Cell Lung 12Biliary Tract Neoplasms 12Adenocarcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Gastrointestinal Neoplasms 6Leukemia, Biphenotypic, Acute 5Gallbladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Advanced Solid Tumors 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Leukemia 4Carcinoma, Renal Cell 4Appendiceal Neoplasms 4Urinary Bladder Neoplasms 3

Interventions

Gemcitabine 2130-nm albumin-bound paclitaxel 2paricalcitol 1mitazalimab 1ivosidenib 1Tissue Banks 1Specimen Handling 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Glucose 1Genetic Testing 1Fluorouracil 1Fecal Microbiota Transplantation 1Escitalopram 1Contrast Media 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Leucovorin × 1 year × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡